PROSIEBENSAT1 MED.

The current price of PSM is 7.277 CHF — it has increased by 14.74% in the past 24 hours. Watch PROSIEBENSAT1 MED. stock price performance more closely on the chart.

Depending on the exchange, the stock ticker may vary. For instance, on BX exchange PROSIEBENSAT1 MED. stocks are traded under the ticker PSM.

PROSIEBENSAT1 MED. is going to release the next earnings report on May 14, 2024. Keep track of upcoming events with our Earnings Calendar.

PSM stock is 12.85% volatile and has beta coefficient of 1.92. Track PROSIEBENSAT1 MED. stock price on the chart and check out the list of the most volatile stocks — is PROSIEBENSAT1 MED. there?

PSM earnings for the last quarter are 0.10 CHF per share, whereas the estimation was 0.14 CHF resulting in a −31.32% surprise. The estimated earnings for the next quarter are 0.86 CHF per share. See more details about PROSIEBENSAT1 MED. earnings.

PROSIEBENSAT1 MED. revenue for the last quarter amounts to ‪859.38 M‬ CHF despite the estimated figure of ‪860.45 M‬ CHF. In the next quarter revenue is expected to reach ‪1.21 B‬ CHF.

Today PROSIEBENSAT1 MED. has the market capitalization of ‪1.57 B‬, it has decreased by 4.88% over the last week.

Yes, PSM dividends are paid annually. The last dividend per share was 0.05 CHF. As of today, Dividend Yield (TTM)% is 0.70%. Tracking PROSIEBENSAT1 MED. dividends might help you take more informed decisions.

Like other stocks, PSM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PROSIEBENSAT1 MED. stock right from TradingView charts — choose your broker and connect to your account.

PSM reached its all-time high on Jun 30, 2021 with the price of 18.385 CHF, and its all-time low was 4.744 CHF and was reached on Oct 27, 2023. View more price dynamics on PSM chart.
See other stocks reaching their highest and lowest prices.

As of May 6, 2024, the company has ‪7.19 K‬ employees. See our rating of the largest employees — is PROSIEBENSAT1 MED. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PROSIEBENSAT1 MED. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PROSIEBENSAT1 MED. stock shows the neutral signal. See more of PROSIEBENSAT1 MED. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.